论文部分内容阅读
目的观察热毒宁注射液治疗儿童急性上呼吸道感染的疗效和安全性。方法将110例急性上呼吸道感染患儿随机分为观察组60例和对照组50例,在液体疗法及对症治疗基础上,观察组应用热毒宁注射液,对照组给予利巴韦林注射液治疗,观察两个组别的发热、症状和体征消失时间和治疗疗效,有无不良反应。结果观察组的退热时间、症状和体征消失时间均显著低于对照组(P<0.01);观察组的总有效率为95.0%,明显高于对照组的82.0%(P<0.05)。结论热毒宁注射液治疗儿童急性上呼吸道感染,疗效好,未见严重不良反应。
Objective To observe the efficacy and safety of Rendunning injection in the treatment of acute upper respiratory tract infection in children. Methods A total of 110 children with acute upper respiratory tract infection were randomly divided into observation group (60 cases) and control group (50 cases). On the basis of liquid therapy and symptomatic treatment, the observation group was treated with Rebutarin Injection and the control group with ribavirin injection The two groups were observed fever, symptoms and signs of disappearance of time and treatment efficacy, with or without adverse reactions. Results The antipyretic time, the disappearance of symptoms and signs in the observation group were significantly lower than those in the control group (P <0.01). The total effective rate in the observation group was 95.0%, which was significantly higher than that in the control group (82.0%, P <0.05). Conclusion Reveduning injection in children with acute upper respiratory tract infection, good effect, no serious adverse reactions.